Leslie Berg
Concepts (516)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein-Tyrosine Kinases | 60 | 2021 | 433 | 9.860 |
Why?
| | CD8-Positive T-Lymphocytes | 23 | 2026 | 917 | 4.200 |
Why?
| | Receptors, Antigen, T-Cell | 41 | 2024 | 668 | 3.900 |
Why?
| | T-Lymphocytes | 46 | 2022 | 1982 | 3.880 |
Why?
| | Signal Transduction | 51 | 2024 | 5226 | 3.080 |
Why?
| | Cell Differentiation | 41 | 2017 | 2050 | 3.040 |
Why?
| | Lymphocyte Activation | 32 | 2024 | 1126 | 2.990 |
Why?
| | CD4-Positive T-Lymphocytes | 25 | 2016 | 1129 | 2.360 |
Why?
| | Interferon Regulatory Factors | 5 | 2020 | 44 | 2.010 |
Why?
| | Lymphocytic choriomeningitis virus | 7 | 2017 | 36 | 1.850 |
Why?
| | Thymus Gland | 24 | 2014 | 311 | 1.720 |
Why?
| | Mice | 91 | 2026 | 18339 | 1.330 |
Why?
| | T-Lymphocyte Subsets | 13 | 2014 | 415 | 1.290 |
Why?
| | Mice, Knockout | 31 | 2020 | 3121 | 1.240 |
Why?
| | Interleukin-15 | 5 | 2026 | 97 | 1.190 |
Why?
| | Animals | 111 | 2026 | 38058 | 1.190 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 11 | 2017 | 331 | 1.190 |
Why?
| | Janus Kinase 3 | 16 | 2009 | 19 | 1.050 |
Why?
| | Intestines | 3 | 2020 | 358 | 1.030 |
Why?
| | Mice, Inbred C57BL | 41 | 2026 | 5992 | 1.010 |
Why?
| | Lymphocytic Choriomeningitis | 4 | 2015 | 25 | 0.990 |
Why?
| | Lymphocytes | 5 | 2019 | 382 | 0.980 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 7 | 2014 | 100 | 0.950 |
Why?
| | Proto-Oncogene Proteins c-vav | 1 | 2024 | 2 | 0.860 |
Why?
| | Th1 Cells | 4 | 2015 | 139 | 0.860 |
Why?
| | T-Box Domain Proteins | 6 | 2015 | 106 | 0.820 |
Why?
| | Immunologic Memory | 8 | 2017 | 366 | 0.810 |
Why?
| | Mice, Transgenic | 32 | 2015 | 2182 | 0.780 |
Why?
| | Cell Proliferation | 7 | 2020 | 2496 | 0.760 |
Why?
| | Chemotaxis, Leukocyte | 3 | 2020 | 113 | 0.740 |
Why?
| | Interleukin Receptor Common gamma Subunit | 3 | 2019 | 14 | 0.740 |
Why?
| | Cells, Cultured | 16 | 2021 | 4154 | 0.720 |
Why?
| | Flow Cytometry | 16 | 2022 | 1173 | 0.690 |
Why?
| | Arenaviridae Infections | 3 | 2017 | 17 | 0.650 |
Why?
| | Autoimmune Diseases | 2 | 2024 | 463 | 0.640 |
Why?
| | CD4 Antigens | 9 | 2007 | 139 | 0.640 |
Why?
| | Killer Cells, Natural | 5 | 2014 | 467 | 0.620 |
Why?
| | Calcium | 3 | 2022 | 1183 | 0.610 |
Why?
| | Cytokines | 7 | 2009 | 2061 | 0.570 |
Why?
| | Transcription Factors | 11 | 2016 | 1741 | 0.560 |
Why?
| | Natural Killer T-Cells | 3 | 2014 | 67 | 0.540 |
Why?
| | Kruppel-Like Transcription Factors | 3 | 2014 | 78 | 0.530 |
Why?
| | Influenza A virus | 3 | 2016 | 113 | 0.530 |
Why?
| | Orthomyxoviridae Infections | 2 | 2016 | 72 | 0.520 |
Why?
| | Th2 Cells | 3 | 2009 | 171 | 0.490 |
Why?
| | Interleukin-2 | 9 | 2019 | 437 | 0.490 |
Why?
| | Colitis | 2 | 2019 | 280 | 0.490 |
Why?
| | Enhancer Elements, Genetic | 2 | 2017 | 192 | 0.470 |
Why?
| | Molecular Sequence Data | 21 | 2015 | 2930 | 0.440 |
Why?
| | Models, Immunological | 5 | 2012 | 100 | 0.430 |
Why?
| | Amino Acid Sequence | 19 | 2015 | 2155 | 0.430 |
Why?
| | Brain | 2 | 2026 | 2933 | 0.410 |
Why?
| | Repressor Proteins | 1 | 2017 | 437 | 0.410 |
Why?
| | NFATC Transcription Factors | 6 | 2021 | 93 | 0.410 |
Why?
| | CD28 Antigens | 5 | 2013 | 58 | 0.410 |
Why?
| | Interferon-gamma | 6 | 2016 | 784 | 0.390 |
Why?
| | Nuclear Proteins | 4 | 2003 | 748 | 0.390 |
Why?
| | Ephrins | 2 | 2002 | 8 | 0.380 |
Why?
| | Gene Expression Regulation | 7 | 2021 | 2608 | 0.380 |
Why?
| | Receptor-CD3 Complex, Antigen, T-Cell | 3 | 2001 | 9 | 0.380 |
Why?
| | Inflammation | 1 | 2024 | 2878 | 0.380 |
Why?
| | Allergy and Immunology | 1 | 2012 | 42 | 0.370 |
Why?
| | Histocompatibility Antigens Class I | 4 | 2010 | 202 | 0.360 |
Why?
| | Membrane Proteins | 4 | 2015 | 1166 | 0.360 |
Why?
| | Phosphorylation | 11 | 2018 | 1732 | 0.350 |
Why?
| | Protein Kinase Inhibitors | 2 | 2015 | 969 | 0.340 |
Why?
| | Antigens, CD | 6 | 2016 | 555 | 0.340 |
Why?
| | Interleukin-4 | 5 | 2014 | 206 | 0.340 |
Why?
| | Epigenesis, Genetic | 2 | 2013 | 684 | 0.330 |
Why?
| | Phospholipase C gamma | 5 | 2018 | 28 | 0.320 |
Why?
| | Cellular Senescence | 1 | 2013 | 226 | 0.320 |
Why?
| | Adoptive Transfer | 3 | 2020 | 198 | 0.300 |
Why?
| | Thymocytes | 3 | 2014 | 34 | 0.300 |
Why?
| | Apoptosis | 6 | 2014 | 2430 | 0.290 |
Why?
| | Proto-Oncogene Proteins c-abl | 1 | 2008 | 6 | 0.290 |
Why?
| | X-Linked Combined Immunodeficiency Diseases | 1 | 2008 | 2 | 0.290 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2009 | 131 | 0.290 |
Why?
| | Major Histocompatibility Complex | 5 | 1997 | 229 | 0.290 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2010 | 230 | 0.280 |
Why?
| | Sequence Homology, Amino Acid | 5 | 2013 | 396 | 0.270 |
Why?
| | Protein Interaction Domains and Motifs | 2 | 2019 | 148 | 0.270 |
Why?
| | Phosphoproteins | 2 | 2001 | 344 | 0.270 |
Why?
| | src Homology Domains | 5 | 2003 | 35 | 0.260 |
Why?
| | src-Family Kinases | 3 | 2018 | 93 | 0.260 |
Why?
| | Bystander Effect | 2 | 2026 | 19 | 0.260 |
Why?
| | Immunoglobulin E | 1 | 2009 | 315 | 0.260 |
Why?
| | Tyrosine | 4 | 2013 | 222 | 0.260 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2008 | 109 | 0.260 |
Why?
| | CD8 Antigens | 6 | 2007 | 72 | 0.260 |
Why?
| | Cell Lineage | 7 | 2015 | 376 | 0.260 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2009 | 381 | 0.260 |
Why?
| | Cell Cycle | 1 | 2009 | 596 | 0.240 |
Why?
| | Promyelocytic Leukemia Zinc Finger Protein | 3 | 2014 | 8 | 0.240 |
Why?
| | Receptors, Eph Family | 2 | 2002 | 6 | 0.240 |
Why?
| | Cytotoxicity, Immunologic | 3 | 2016 | 223 | 0.240 |
Why?
| | Antigens, Differentiation | 3 | 2004 | 77 | 0.240 |
Why?
| | Lymphopenia | 2 | 2008 | 65 | 0.230 |
Why?
| | B-Lymphocytes | 4 | 2009 | 876 | 0.230 |
Why?
| | Mast Cells | 1 | 2007 | 146 | 0.230 |
Why?
| | Humans | 39 | 2024 | 144759 | 0.220 |
Why?
| | Up-Regulation | 6 | 2014 | 851 | 0.210 |
Why?
| | Antigens, CD1d | 2 | 2014 | 68 | 0.210 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 983 | 0.210 |
Why?
| | Autoimmunity | 2 | 2024 | 926 | 0.210 |
Why?
| | Ligands | 8 | 2009 | 673 | 0.210 |
Why?
| | Gene Expression | 5 | 2014 | 1490 | 0.210 |
Why?
| | Microglia | 1 | 2026 | 268 | 0.200 |
Why?
| | Enzyme Activation | 6 | 2010 | 766 | 0.200 |
Why?
| | Receptor, EphA1 | 1 | 2002 | 2 | 0.190 |
Why?
| | Receptors, Lymphocyte Homing | 2 | 2020 | 15 | 0.190 |
Why?
| | MAP Kinase Signaling System | 2 | 2021 | 310 | 0.190 |
Why?
| | Homeostasis | 3 | 2013 | 640 | 0.190 |
Why?
| | Down-Regulation | 3 | 2010 | 627 | 0.190 |
Why?
| | Histocompatibility Antigens Class II | 4 | 1999 | 364 | 0.190 |
Why?
| | Cytoplasm | 2 | 2022 | 269 | 0.190 |
Why?
| | Phosphatidylinositol 3-Kinases | 3 | 2002 | 380 | 0.190 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2024 | 101 | 0.190 |
Why?
| | Membrane Glycoproteins | 2 | 2002 | 496 | 0.190 |
Why?
| | Interleukin-17 | 3 | 2013 | 118 | 0.190 |
Why?
| | Jurkat Cells | 6 | 2009 | 114 | 0.180 |
Why?
| | Cell Line | 7 | 2015 | 2882 | 0.180 |
Why?
| | Stomach Neoplasms | 1 | 2024 | 126 | 0.180 |
Why?
| | Type C Phospholipases | 4 | 2003 | 69 | 0.180 |
Why?
| | Gene Expression Regulation, Developmental | 3 | 2004 | 905 | 0.180 |
Why?
| | NF-kappa B | 2 | 2021 | 661 | 0.170 |
Why?
| | Immunophenotyping | 5 | 2016 | 322 | 0.170 |
Why?
| | H-2 Antigens | 3 | 2014 | 111 | 0.170 |
Why?
| | CD3 Complex | 2 | 2009 | 111 | 0.170 |
Why?
| | Promoter Regions, Genetic | 4 | 2014 | 1257 | 0.170 |
Why?
| | Molecular Targeted Therapy | 1 | 2024 | 432 | 0.170 |
Why?
| | Stem Cells | 3 | 2001 | 626 | 0.170 |
Why?
| | Polymerase Chain Reaction | 4 | 2017 | 1054 | 0.170 |
Why?
| | Receptors, Immunologic | 1 | 2002 | 206 | 0.170 |
Why?
| | Male | 17 | 2021 | 72315 | 0.170 |
Why?
| | Hematopoiesis | 4 | 2010 | 194 | 0.160 |
Why?
| | Tacrolimus | 1 | 2001 | 196 | 0.160 |
Why?
| | Positive Regulatory Domain I-Binding Factor 1 | 3 | 2016 | 17 | 0.160 |
Why?
| | Macrophages | 2 | 2026 | 1511 | 0.160 |
Why?
| | Hematopoietic Stem Cells | 4 | 1999 | 420 | 0.160 |
Why?
| | Rhadinovirus | 1 | 2020 | 20 | 0.160 |
Why?
| | History, 21st Century | 2 | 2012 | 219 | 0.160 |
Why?
| | History, 20th Century | 2 | 2012 | 325 | 0.150 |
Why?
| | Protein Binding | 6 | 2018 | 2273 | 0.150 |
Why?
| | Antigens, Differentiation, T-Lymphocyte | 4 | 2016 | 100 | 0.150 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2000 | 427 | 0.150 |
Why?
| | Spleen | 4 | 2014 | 508 | 0.150 |
Why?
| | Immunoconjugates | 1 | 2001 | 132 | 0.150 |
Why?
| | Cricetinae | 3 | 2015 | 303 | 0.150 |
Why?
| | Receptors, Cytokine | 1 | 1999 | 36 | 0.150 |
Why?
| | Sea Urchins | 2 | 1998 | 7 | 0.150 |
Why?
| | Interleukin-33 | 1 | 2019 | 45 | 0.140 |
Why?
| | Blood Proteins | 1 | 2001 | 249 | 0.140 |
Why?
| | Hepatocyte Nuclear Factor 1-alpha | 2 | 2015 | 21 | 0.140 |
Why?
| | Base Sequence | 7 | 1997 | 2190 | 0.140 |
Why?
| | Chronic Disease | 1 | 2024 | 1813 | 0.140 |
Why?
| | DNA-Binding Proteins | 5 | 2006 | 1499 | 0.130 |
Why?
| | DNA | 3 | 2021 | 1463 | 0.130 |
Why?
| | Recombinant Fusion Proteins | 6 | 2001 | 675 | 0.130 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2017 | 139 | 0.130 |
Why?
| | NK Cell Lectin-Like Receptor Subfamily C | 1 | 2016 | 9 | 0.130 |
Why?
| | Immunologic Deficiency Syndromes | 1 | 1997 | 65 | 0.130 |
Why?
| | Peptide Fragments | 4 | 1997 | 699 | 0.130 |
Why?
| | Phenotype | 5 | 2006 | 3162 | 0.120 |
Why?
| | Virus Replication | 1 | 2020 | 529 | 0.120 |
Why?
| | Clonal Deletion | 4 | 2001 | 16 | 0.120 |
Why?
| | Seals, Earless | 2 | 2006 | 5 | 0.120 |
Why?
| | Lymph Nodes | 2 | 2014 | 502 | 0.120 |
Why?
| | Hematopoietic System | 1 | 1996 | 7 | 0.120 |
Why?
| | Methylation | 2 | 2014 | 242 | 0.120 |
Why?
| | Microscopy, Confocal | 1 | 2017 | 321 | 0.120 |
Why?
| | Mutation | 5 | 2013 | 4089 | 0.120 |
Why?
| | Mass Spectrometry | 1 | 2019 | 750 | 0.120 |
Why?
| | Biomarkers | 4 | 2024 | 4271 | 0.120 |
Why?
| | Chemokine CCL20 | 1 | 2015 | 5 | 0.120 |
Why?
| | Chemokine CXCL11 | 1 | 2015 | 3 | 0.120 |
Why?
| | Binding Sites | 7 | 2013 | 1329 | 0.120 |
Why?
| | Homeodomain Proteins | 2 | 2019 | 523 | 0.120 |
Why?
| | Introns | 1 | 1997 | 254 | 0.120 |
Why?
| | Lymphoid Tissue | 1 | 1996 | 80 | 0.120 |
Why?
| | Receptors, Interleukin-7 | 3 | 2001 | 28 | 0.120 |
Why?
| | Exons | 1 | 1997 | 358 | 0.110 |
Why?
| | Germinal Center | 1 | 2015 | 67 | 0.110 |
Why?
| | Protein Structure, Tertiary | 4 | 2013 | 862 | 0.110 |
Why?
| | Interferon Type I | 1 | 2016 | 145 | 0.110 |
Why?
| | Transfection | 5 | 2001 | 940 | 0.110 |
Why?
| | Oligopeptides | 1 | 1996 | 269 | 0.110 |
Why?
| | Cell Survival | 3 | 2014 | 1098 | 0.110 |
Why?
| | Th17 Cells | 1 | 2015 | 101 | 0.110 |
Why?
| | Female | 16 | 2021 | 78271 | 0.110 |
Why?
| | Animal Structures | 1 | 2014 | 11 | 0.110 |
Why?
| | beta 2-Microglobulin | 1 | 2014 | 47 | 0.110 |
Why?
| | S100 Proteins | 1 | 2014 | 36 | 0.100 |
Why?
| | Annexin A2 | 1 | 2014 | 13 | 0.100 |
Why?
| | Prion Diseases | 1 | 1994 | 15 | 0.100 |
Why?
| | Spodoptera | 3 | 2010 | 40 | 0.100 |
Why?
| | Cell Movement | 2 | 2013 | 965 | 0.100 |
Why?
| | Citalopram | 1 | 2014 | 32 | 0.100 |
Why?
| | Cytochrome c Group | 4 | 2002 | 43 | 0.100 |
Why?
| | Histone Deacetylase 2 | 1 | 2013 | 10 | 0.100 |
Why?
| | Tumor Necrosis Factor Receptor Superfamily, Member 7 | 1 | 2013 | 28 | 0.100 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2013 | 80 | 0.100 |
Why?
| | Polycomb Repressive Complex 2 | 1 | 2014 | 81 | 0.100 |
Why?
| | Cell Migration Inhibition | 1 | 2013 | 16 | 0.100 |
Why?
| | Resting Phase, Cell Cycle | 2 | 2010 | 16 | 0.100 |
Why?
| | Mice, Mutant Strains | 2 | 2008 | 299 | 0.100 |
Why?
| | High Mobility Group Proteins | 1 | 2013 | 45 | 0.100 |
Why?
| | Lymphocyte Subsets | 1 | 2013 | 83 | 0.100 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2013 | 134 | 0.090 |
Why?
| | Antidepressive Agents | 1 | 2014 | 248 | 0.090 |
Why?
| | Animals, Newborn | 3 | 2006 | 902 | 0.090 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2013 | 141 | 0.090 |
Why?
| | Forkhead Transcription Factors | 1 | 2012 | 202 | 0.090 |
Why?
| | Histones | 2 | 2014 | 669 | 0.090 |
Why?
| | RNA, Small Interfering | 1 | 2013 | 635 | 0.080 |
Why?
| | Autoantigens | 2 | 2013 | 429 | 0.080 |
Why?
| | Acute Disease | 1 | 2014 | 1030 | 0.080 |
Why?
| | Monocytes | 1 | 2014 | 538 | 0.080 |
Why?
| | Transcription, Genetic | 4 | 2015 | 1496 | 0.080 |
Why?
| | Arthritis, Rheumatoid | 1 | 2000 | 1169 | 0.080 |
Why?
| | Alleles | 3 | 1995 | 879 | 0.080 |
Why?
| | Kinetics | 4 | 2013 | 1627 | 0.080 |
Why?
| | Transplantation Chimera | 1 | 2010 | 56 | 0.080 |
Why?
| | Isoenzymes | 2 | 2002 | 299 | 0.080 |
Why?
| | Mitogen-Activated Protein Kinases | 2 | 2002 | 292 | 0.080 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2011 | 159 | 0.080 |
Why?
| | Interferon-beta | 1 | 2010 | 92 | 0.080 |
Why?
| | Mitosis | 1 | 2011 | 200 | 0.080 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2012 | 389 | 0.080 |
Why?
| | Phosphotyrosine | 2 | 2001 | 39 | 0.080 |
Why?
| | Transcription Factors, TFII | 1 | 2009 | 44 | 0.070 |
Why?
| | Cell Line, Tumor | 2 | 2009 | 3540 | 0.070 |
Why?
| | Cord Blood Stem Cell Transplantation | 1 | 2010 | 103 | 0.070 |
Why?
| | Immunoglobulin Class Switching | 1 | 2009 | 21 | 0.070 |
Why?
| | Apnea | 2 | 2006 | 25 | 0.070 |
Why?
| | DNA, Complementary | 4 | 2001 | 276 | 0.070 |
Why?
| | Interferon-alpha | 1 | 2010 | 197 | 0.070 |
Why?
| | T-Lymphocytes, Cytotoxic | 3 | 1996 | 177 | 0.070 |
Why?
| | Herpesvirus 2, Human | 1 | 2009 | 27 | 0.070 |
Why?
| | Rats | 2 | 2014 | 5597 | 0.070 |
Why?
| | Immediate-Early Proteins | 1 | 2009 | 48 | 0.070 |
Why?
| | Xenopus Proteins | 2 | 2006 | 37 | 0.070 |
Why?
| | Antigen-Presenting Cells | 2 | 2002 | 160 | 0.070 |
Why?
| | GPI-Linked Proteins | 1 | 2009 | 80 | 0.070 |
Why?
| | Genes | 1 | 1988 | 226 | 0.070 |
Why?
| | Structure-Activity Relationship | 2 | 2001 | 570 | 0.070 |
Why?
| | Neoplasm Transplantation | 1 | 2008 | 251 | 0.070 |
Why?
| | Societies, Medical | 1 | 2012 | 887 | 0.070 |
Why?
| | Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 3 | 1997 | 16 | 0.070 |
Why?
| | STAT5 Transcription Factor | 1 | 2008 | 52 | 0.070 |
Why?
| | STAT Transcription Factors | 1 | 2008 | 24 | 0.070 |
Why?
| | Atrophy | 1 | 2008 | 201 | 0.070 |
Why?
| | Organ Culture Techniques | 2 | 2001 | 154 | 0.070 |
Why?
| | Herpes Simplex | 1 | 2009 | 98 | 0.070 |
Why?
| | Herpesvirus 1, Human | 1 | 2009 | 84 | 0.070 |
Why?
| | Time Factors | 5 | 2010 | 7173 | 0.070 |
Why?
| | Mice, Inbred C3H | 2 | 1999 | 251 | 0.070 |
Why?
| | Conserved Sequence | 3 | 1998 | 245 | 0.070 |
Why?
| | CD5 Antigens | 2 | 2002 | 10 | 0.070 |
Why?
| | Multigene Family | 1 | 2008 | 204 | 0.060 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2009 | 192 | 0.060 |
Why?
| | Clone Cells | 2 | 2001 | 266 | 0.060 |
Why?
| | HeLa Cells | 1 | 2009 | 650 | 0.060 |
Why?
| | Severe Combined Immunodeficiency | 2 | 1997 | 22 | 0.060 |
Why?
| | CTLA-4 Antigen | 2 | 2013 | 104 | 0.060 |
Why?
| | Tissue Donors | 1 | 2010 | 424 | 0.060 |
Why?
| | Disease Susceptibility | 1 | 2008 | 348 | 0.060 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2008 | 269 | 0.060 |
Why?
| | Antigens, Surface | 2 | 2014 | 157 | 0.060 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 851 | 0.060 |
Why?
| | Disease Models, Animal | 1 | 2017 | 4557 | 0.060 |
Why?
| | Mutagenesis, Site-Directed | 2 | 1997 | 381 | 0.060 |
Why?
| | Macromolecular Substances | 2 | 2001 | 224 | 0.060 |
Why?
| | Mice, Inbred BALB C | 5 | 2016 | 1253 | 0.060 |
Why?
| | Hyaluronan Receptors | 1 | 2006 | 102 | 0.060 |
Why?
| | Veins | 1 | 2006 | 68 | 0.060 |
Why?
| | Bone Marrow Cells | 3 | 2014 | 320 | 0.060 |
Why?
| | Disease Progression | 1 | 2013 | 2847 | 0.060 |
Why?
| | Immunity, Innate | 2 | 2013 | 846 | 0.060 |
Why?
| | Lysine | 2 | 2014 | 302 | 0.060 |
Why?
| | Cardiac Output | 1 | 2006 | 179 | 0.060 |
Why?
| | Transcriptome | 1 | 2012 | 1045 | 0.060 |
Why?
| | Lectins, C-Type | 2 | 2016 | 62 | 0.060 |
Why?
| | Point Mutation | 3 | 2010 | 243 | 0.060 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2005 | 72 | 0.060 |
Why?
| | RNA, Messenger | 4 | 1998 | 2832 | 0.050 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2005 | 81 | 0.050 |
Why?
| | Genetic Variation | 1 | 1990 | 983 | 0.050 |
Why?
| | Recombinant Proteins | 3 | 1997 | 1370 | 0.050 |
Why?
| | Protein Conformation | 3 | 2000 | 946 | 0.050 |
Why?
| | Alternative Splicing | 2 | 1997 | 247 | 0.050 |
Why?
| | Molecular Structure | 1 | 2005 | 499 | 0.050 |
Why?
| | Proto-Oncogene Proteins | 2 | 2005 | 623 | 0.050 |
Why?
| | In Vitro Techniques | 1 | 2005 | 1047 | 0.050 |
Why?
| | Leukosialin | 2 | 2009 | 12 | 0.050 |
Why?
| | Herpesvirus 4, Human | 1 | 2024 | 176 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2005 | 436 | 0.050 |
Why?
| | Signaling Lymphocytic Activation Molecule Family | 1 | 2002 | 7 | 0.050 |
Why?
| | Dose-Response Relationship, Immunologic | 1 | 2002 | 76 | 0.050 |
Why?
| | Genes, T-Cell Receptor | 1 | 2002 | 6 | 0.050 |
Why?
| | Heart | 1 | 2006 | 636 | 0.050 |
Why?
| | Hybridomas | 2 | 2000 | 234 | 0.050 |
Why?
| | Fas Ligand Protein | 1 | 2002 | 60 | 0.040 |
Why?
| | ZAP-70 Protein-Tyrosine Kinase | 1 | 2001 | 10 | 0.040 |
Why?
| | Tacrolimus Binding Protein 1A | 1 | 2001 | 10 | 0.040 |
Why?
| | Cysteine | 2 | 2001 | 210 | 0.040 |
Why?
| | B7-H1 Antigen | 1 | 2024 | 241 | 0.040 |
Why?
| | Transgenes | 1 | 2002 | 189 | 0.040 |
Why?
| | Fetus | 2 | 2012 | 803 | 0.040 |
Why?
| | Dimerization | 1 | 2001 | 194 | 0.040 |
Why?
| | Embryo, Nonmammalian | 2 | 2001 | 173 | 0.040 |
Why?
| | Gene Rearrangement, T-Lymphocyte | 1 | 2001 | 16 | 0.040 |
Why?
| | Amino Acid Motifs | 1 | 2001 | 224 | 0.040 |
Why?
| | Genes, Reporter | 1 | 2001 | 275 | 0.040 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2001 | 142 | 0.040 |
Why?
| | Injections, Intralymphatic | 1 | 2000 | 1 | 0.040 |
Why?
| | Tumor Cells, Cultured | 3 | 1999 | 919 | 0.040 |
Why?
| | Cell Division | 2 | 2000 | 766 | 0.040 |
Why?
| | Abatacept | 1 | 2001 | 56 | 0.040 |
Why?
| | Cross-Linking Reagents | 1 | 2001 | 207 | 0.040 |
Why?
| | Mice, Congenic | 1 | 2000 | 23 | 0.040 |
Why?
| | Calcium Signaling | 1 | 2003 | 251 | 0.040 |
Why?
| | Phosphatidylinositol Phosphates | 1 | 2001 | 41 | 0.040 |
Why?
| | Androstadienes | 1 | 2001 | 76 | 0.040 |
Why?
| | Embryonic and Fetal Development | 1 | 2000 | 93 | 0.040 |
Why?
| | Stromal Cells | 1 | 2001 | 124 | 0.040 |
Why?
| | Granulocytes | 1 | 2000 | 80 | 0.040 |
Why?
| | Synovial Fluid | 1 | 2000 | 67 | 0.040 |
Why?
| | Enzyme Inhibitors | 2 | 2001 | 824 | 0.040 |
Why?
| | Detergents | 1 | 2000 | 44 | 0.040 |
Why?
| | Interphase | 1 | 1999 | 38 | 0.040 |
Why?
| | Cell Line, Transformed | 2 | 1999 | 140 | 0.040 |
Why?
| | Amino Acid Substitution | 1 | 2001 | 304 | 0.040 |
Why?
| | Leukopoiesis | 1 | 1999 | 11 | 0.040 |
Why?
| | Antibodies, Blocking | 1 | 1999 | 37 | 0.040 |
Why?
| | Immune Tolerance | 2 | 1994 | 379 | 0.040 |
Why?
| | Arginine | 1 | 2001 | 262 | 0.040 |
Why?
| | Stem Cell Factor | 1 | 1999 | 17 | 0.040 |
Why?
| | Blood Pressure | 1 | 2006 | 1769 | 0.040 |
Why?
| | Bone Marrow Transplantation | 1 | 2000 | 294 | 0.040 |
Why?
| | Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 1998 | 8 | 0.040 |
Why?
| | Chemokines, CXC | 1 | 1999 | 68 | 0.040 |
Why?
| | Interleukin-7 | 1 | 1999 | 65 | 0.040 |
Why?
| | Chemokine CXCL12 | 1 | 1999 | 89 | 0.040 |
Why?
| | Glutamic Acid | 1 | 2001 | 251 | 0.040 |
Why?
| | Biological Transport | 1 | 1999 | 417 | 0.030 |
Why?
| | Hyalin | 1 | 1998 | 3 | 0.030 |
Why?
| | Ion Transport | 1 | 1998 | 63 | 0.030 |
Why?
| | Cricetulus | 2 | 2013 | 118 | 0.030 |
Why?
| | Gene Rearrangement | 1 | 1999 | 155 | 0.030 |
Why?
| | Vanadates | 1 | 1997 | 17 | 0.030 |
Why?
| | Phosphopeptides | 1 | 1997 | 20 | 0.030 |
Why?
| | Antigens, Neoplasm | 1 | 1999 | 271 | 0.030 |
Why?
| | Lymphocyte Count | 1 | 1997 | 164 | 0.030 |
Why?
| | Receptors, Interleukin-2 | 2 | 1999 | 64 | 0.030 |
Why?
| | Selection, Genetic | 2 | 1989 | 256 | 0.030 |
Why?
| | Molecular Weight | 2 | 1999 | 327 | 0.030 |
Why?
| | DNA Primers | 2 | 1995 | 512 | 0.030 |
Why?
| | Species Specificity | 2 | 2006 | 574 | 0.030 |
Why?
| | Receptor, EphB6 | 1 | 1996 | 1 | 0.030 |
Why?
| | Gene Deletion | 2 | 1999 | 389 | 0.030 |
Why?
| | Antibodies, Monoclonal | 3 | 1999 | 1519 | 0.030 |
Why?
| | Receptors, Interleukin | 1 | 1996 | 43 | 0.030 |
Why?
| | Agammaglobulinemia | 1 | 1996 | 36 | 0.030 |
Why?
| | Homozygote | 1 | 1997 | 199 | 0.030 |
Why?
| | Enzyme Induction | 1 | 1996 | 88 | 0.030 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 1996 | 56 | 0.030 |
Why?
| | Blotting, Western | 2 | 2013 | 1187 | 0.030 |
Why?
| | Mice, SCID | 2 | 2013 | 369 | 0.030 |
Why?
| | Chickens | 1 | 1996 | 191 | 0.030 |
Why?
| | Poly I-C | 1 | 2016 | 57 | 0.030 |
Why?
| | Receptors, CXCR5 | 1 | 2015 | 27 | 0.030 |
Why?
| | Carrier Proteins | 1 | 2000 | 737 | 0.030 |
Why?
| | Cloning, Molecular | 2 | 1995 | 540 | 0.030 |
Why?
| | Leukocyte Common Antigens | 1 | 1995 | 88 | 0.030 |
Why?
| | Gene Targeting | 1 | 1995 | 82 | 0.030 |
Why?
| | Muscle, Skeletal | 1 | 2006 | 1795 | 0.030 |
Why?
| | Crosses, Genetic | 1 | 2015 | 124 | 0.030 |
Why?
| | Sequence Alignment | 1 | 1996 | 366 | 0.030 |
Why?
| | Sialoglycoproteins | 1 | 1995 | 158 | 0.030 |
Why?
| | Organ Specificity | 1 | 1996 | 312 | 0.030 |
Why?
| | Feedback, Physiological | 1 | 2015 | 83 | 0.030 |
Why?
| | Interferon Regulatory Factor-3 | 1 | 2015 | 16 | 0.030 |
Why?
| | Consensus Sequence | 1 | 1995 | 74 | 0.030 |
Why?
| | Ovum | 1 | 1995 | 31 | 0.030 |
Why?
| | Ribonucleases | 1 | 1995 | 49 | 0.030 |
Why?
| | Lasers | 1 | 1995 | 132 | 0.030 |
Why?
| | GTP Phosphohydrolases | 1 | 1995 | 93 | 0.030 |
Why?
| | Adult | 3 | 2014 | 40449 | 0.030 |
Why?
| | GTP-Binding Proteins | 1 | 1995 | 153 | 0.030 |
Why?
| | Immunosuppressive Agents | 1 | 1999 | 846 | 0.030 |
Why?
| | Protein Processing, Post-Translational | 1 | 1997 | 477 | 0.030 |
Why?
| | Zinc Fingers | 1 | 2014 | 53 | 0.030 |
Why?
| | Stochastic Processes | 1 | 1994 | 71 | 0.030 |
Why?
| | Epitopes | 1 | 1996 | 485 | 0.030 |
Why?
| | Immunoglobulin M | 1 | 1995 | 284 | 0.030 |
Why?
| | Scrapie | 1 | 1994 | 3 | 0.030 |
Why?
| | Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 1 | 1994 | 21 | 0.030 |
Why?
| | PrPSc Proteins | 1 | 1994 | 8 | 0.030 |
Why?
| | Biomarkers, Pharmacological | 1 | 2014 | 26 | 0.030 |
Why?
| | CD4-CD8 Ratio | 1 | 1994 | 23 | 0.030 |
Why?
| | Dendritic Cells | 2 | 2015 | 499 | 0.030 |
Why?
| | Regional Blood Flow | 2 | 2006 | 514 | 0.030 |
Why?
| | Sf9 Cells | 1 | 2013 | 11 | 0.030 |
Why?
| | Viral Proteins | 1 | 1996 | 355 | 0.030 |
Why?
| | Deuterium Exchange Measurement | 1 | 2013 | 27 | 0.030 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 1995 | 167 | 0.030 |
Why?
| | Prions | 1 | 1994 | 50 | 0.030 |
Why?
| | CHO Cells | 1 | 2013 | 171 | 0.020 |
Why?
| | Interferons | 1 | 2015 | 188 | 0.020 |
Why?
| | Natural Cytotoxicity Triggering Receptor 1 | 1 | 2013 | 3 | 0.020 |
Why?
| | Lymphoid Enhancer-Binding Factor 1 | 1 | 2013 | 6 | 0.020 |
Why?
| | SOXC Transcription Factors | 1 | 2013 | 9 | 0.020 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2013 | 14 | 0.020 |
Why?
| | Cell Separation | 1 | 2014 | 307 | 0.020 |
Why?
| | Biocatalysis | 1 | 2013 | 69 | 0.020 |
Why?
| | Antigens, Ly | 1 | 2013 | 40 | 0.020 |
Why?
| | Genes, abl | 1 | 1993 | 4 | 0.020 |
Why?
| | Genes, src | 1 | 1993 | 5 | 0.020 |
Why?
| | Middle Aged | 2 | 2009 | 35875 | 0.020 |
Why?
| | Evolution, Molecular | 1 | 1997 | 514 | 0.020 |
Why?
| | Microtubules | 1 | 1995 | 286 | 0.020 |
Why?
| | CD24 Antigen | 1 | 2012 | 18 | 0.020 |
Why?
| | Host-Pathogen Interactions | 1 | 2015 | 371 | 0.020 |
Why?
| | Tissue Distribution | 1 | 1993 | 327 | 0.020 |
Why?
| | Models, Molecular | 2 | 2013 | 1618 | 0.020 |
Why?
| | Haplotypes | 1 | 1994 | 490 | 0.020 |
Why?
| | Young Adult | 1 | 2009 | 14105 | 0.020 |
Why?
| | Heart Rate | 2 | 2006 | 855 | 0.020 |
Why?
| | Mice, Inbred NOD | 1 | 2013 | 610 | 0.020 |
Why?
| | Principal Component Analysis | 1 | 2012 | 197 | 0.020 |
Why?
| | Interleukins | 1 | 2013 | 248 | 0.020 |
Why?
| | Cell Cycle Proteins | 1 | 1995 | 628 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2013 | 383 | 0.020 |
Why?
| | Precipitin Tests | 2 | 2001 | 93 | 0.020 |
Why?
| | Pichinde virus | 1 | 2010 | 1 | 0.020 |
Why?
| | H-Y Antigen | 1 | 2010 | 11 | 0.020 |
Why?
| | Peptides | 2 | 1996 | 995 | 0.020 |
Why?
| | Mitogens | 1 | 2010 | 55 | 0.020 |
Why?
| | Gene Regulatory Networks | 1 | 2013 | 318 | 0.020 |
Why?
| | K562 Cells | 1 | 2010 | 93 | 0.020 |
Why?
| | Autoantibodies | 2 | 2015 | 1501 | 0.020 |
Why?
| | Baculoviridae | 1 | 2010 | 44 | 0.020 |
Why?
| | Cell Polarity | 1 | 2011 | 137 | 0.020 |
Why?
| | T-Cell Antigen Receptor Specificity | 1 | 1989 | 45 | 0.020 |
Why?
| | NIH 3T3 Cells | 1 | 2010 | 148 | 0.020 |
Why?
| | Genes, fos | 1 | 2009 | 37 | 0.020 |
Why?
| | Proteins | 1 | 1995 | 1021 | 0.020 |
Why?
| | Adolescent | 1 | 2009 | 22428 | 0.020 |
Why?
| | Pseudogenes | 1 | 1988 | 20 | 0.020 |
Why?
| | Blotting, Southern | 1 | 1988 | 85 | 0.020 |
Why?
| | RNA-Binding Proteins | 1 | 1992 | 462 | 0.020 |
Why?
| | Genetic Vectors | 1 | 2010 | 337 | 0.020 |
Why?
| | Mycobacterium tuberculosis | 1 | 2012 | 334 | 0.020 |
Why?
| | Mice, Inbred Strains | 1 | 1988 | 397 | 0.020 |
Why?
| | Age Factors | 2 | 2012 | 3333 | 0.020 |
Why?
| | MicroRNAs | 1 | 2014 | 701 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2000 | 8265 | 0.020 |
Why?
| | Polymorphism, Genetic | 1 | 1990 | 612 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2010 | 1217 | 0.010 |
Why?
| | Models, Cardiovascular | 1 | 2006 | 195 | 0.010 |
Why?
| | Arteries | 1 | 2006 | 259 | 0.010 |
Why?
| | Lung | 1 | 2016 | 4109 | 0.010 |
Why?
| | Temperature | 1 | 2006 | 679 | 0.010 |
Why?
| | Stroke Volume | 1 | 2006 | 651 | 0.010 |
Why?
| | Subtilisins | 1 | 2001 | 9 | 0.010 |
Why?
| | Furin | 1 | 2001 | 13 | 0.010 |
Why?
| | Aging | 1 | 1993 | 1966 | 0.010 |
Why?
| | Xenopus | 1 | 2001 | 89 | 0.010 |
Why?
| | beta-Galactosidase | 1 | 2001 | 77 | 0.010 |
Why?
| | Bone Morphogenetic Protein 4 | 1 | 2001 | 43 | 0.010 |
Why?
| | Pulmonary Artery | 1 | 2006 | 1134 | 0.010 |
Why?
| | Aged | 1 | 2000 | 25913 | 0.010 |
Why?
| | Cell Aggregation | 1 | 1999 | 19 | 0.010 |
Why?
| | Glycosylphosphatidylinositols | 1 | 1999 | 12 | 0.010 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 1999 | 153 | 0.010 |
Why?
| | Lymphoma, T-Cell | 1 | 1999 | 29 | 0.010 |
Why?
| | Receptors, IgG | 1 | 1999 | 76 | 0.010 |
Why?
| | Genes, RAG-1 | 1 | 1998 | 12 | 0.010 |
Why?
| | Hydroxamic Acids | 1 | 1998 | 94 | 0.010 |
Why?
| | Cell Death | 1 | 1999 | 383 | 0.010 |
Why?
| | Ectoderm | 1 | 1998 | 53 | 0.010 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 1998 | 117 | 0.010 |
Why?
| | Histone Deacetylases | 1 | 1998 | 210 | 0.010 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 1998 | 220 | 0.010 |
Why?
| | Receptor Aggregation | 1 | 1996 | 10 | 0.010 |
Why?
| | Receptors, Interleukin-4 | 1 | 1996 | 16 | 0.010 |
Why?
| | Immunologic Techniques | 1 | 1996 | 38 | 0.010 |
Why?
| | Janus Kinase 1 | 1 | 1996 | 26 | 0.010 |
Why?
| | Cell Adhesion | 1 | 1998 | 455 | 0.010 |
Why?
| | Proline | 1 | 1997 | 83 | 0.010 |
Why?
| | Binding, Competitive | 1 | 1996 | 193 | 0.010 |
Why?
| | Vaccines, Synthetic | 1 | 1996 | 138 | 0.010 |
Why?
| | Ovary | 1 | 1998 | 228 | 0.010 |
Why?
| | Rosaniline Dyes | 1 | 1995 | 15 | 0.010 |
Why?
| | GRB2 Adaptor Protein | 1 | 1995 | 12 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-fyn | 1 | 1995 | 11 | 0.010 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 1995 | 48 | 0.010 |
Why?
| | cdc42 GTP-Binding Protein, Saccharomyces cerevisiae | 1 | 1995 | 2 | 0.010 |
Why?
| | Models, Structural | 1 | 1995 | 41 | 0.010 |
Why?
| | Coloring Agents | 1 | 1995 | 93 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 1999 | 1716 | 0.010 |
Why?
| | Photochemistry | 1 | 1995 | 134 | 0.010 |
Why?
| | Chromatin | 1 | 1998 | 561 | 0.010 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 1997 | 630 | 0.010 |
Why?
| | Lymphoma, B-Cell | 1 | 1995 | 132 | 0.010 |
Why?
| | Immunization, Passive | 1 | 1994 | 87 | 0.010 |
Why?
| | DNA Methylation | 1 | 1998 | 681 | 0.010 |
Why?
| | Nucleocapsid Proteins | 1 | 1992 | 28 | 0.010 |
Why?
| | Viral Core Proteins | 1 | 1992 | 22 | 0.010 |
Why?
| | Actins | 1 | 1995 | 425 | 0.010 |
Why?
| | Nucleoproteins | 1 | 1992 | 38 | 0.010 |
Why?
| | Escherichia coli | 1 | 1997 | 854 | 0.010 |
Why?
| | ErbB Receptors | 1 | 1995 | 627 | 0.010 |
Why?
| | RNA | 1 | 1998 | 940 | 0.010 |
Why?
| | Immunization | 1 | 1992 | 374 | 0.010 |
Why?
| | Histocompatibility Antigens | 1 | 1989 | 102 | 0.000 |
Why?
|
|
Berg's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|